No abstract available
MeSH terms
-
Antibodies, Bispecific / therapeutic use*
-
Antineoplastic Agents / therapeutic use*
-
Child
-
Disease-Free Survival
-
Humans
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Recurrence
-
Treatment Outcome
Substances
-
Antibodies, Bispecific
-
Antineoplastic Agents
-
blinatumomab